These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5006206)

  • 1. Monotherapy with rifampicin in pulmonary tuberculosis.
    Saeed AH
    Arch Monaldi; 1971; 26(5):433-9. PubMed ID: 5006206
    [No Abstract]   [Full Text] [Related]  

  • 2. [Investigation on failures in the treatment of pulmonary tuberculosis with rifampicin. Tuberculosis Research Committee. RYOKEN].
    Kekkaku; 1984 Feb; 59(2):91-104. PubMed ID: 6431172
    [No Abstract]   [Full Text] [Related]  

  • 3. Trial of rifampicin in the treatment of pulmonary tuberculosis. Results at 12 months.
    Sriyabhaya N; Jarumilin A
    J Med Assoc Thai; 1972 Apr; 55(4):235-7. PubMed ID: 5022496
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifampicin in the retreatment and original treatment of advanced pulmonary tuberculosis.
    Gyselen A
    Bull Int Union Tuberc; 1970 Jun; 43():60-3. PubMed ID: 4987555
    [No Abstract]   [Full Text] [Related]  

  • 5. Pre- and postoperative treatment of chronic multiresistant cases of pulmonary tuberculosis with rifampicin.
    Rzepecki WM; Lodziak A
    Chemotherapy; 1974; 20(2):12-4. PubMed ID: 4367637
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary results with rifampicin in the treatment of drug-resistant tuberculosis.
    Pines A
    Tubercle; 1969 Mar; 50():Suppl:50-2. PubMed ID: 5402545
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term intravenous rifampicin treatment. Advantages and disadvantages.
    Anker N; Band FC
    Eur J Respir Dis; 1981; 62(2):84-6. PubMed ID: 6453721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Direct genetic analysis of the rifampicin resistance of M. tuberculosis isolates in sputum samples].
    Generozov EV; Akopian TA; Vladimirskiĭ MA; Shipina LK; Irtuganova OA; Govorun VM
    Probl Tuberk Bolezn Legk; 2003; (4):49-52. PubMed ID: 12774423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
    Diacon AH; Patientia RF; Venter A; van Helden PD; Smith PJ; McIlleron H; Maritz JS; Donald PR
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2994-6. PubMed ID: 17517849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histobacteriology of pulmonary resection specimens in patients treated with rifampicin. Clinico-therapeutic conclusions].
    Palombini BC; Wallau CH; Tossin LN; Corrêa IF; Chaieb JA; Vieira VG; Ott WP; Nunes JD; Porto NS
    AMB Rev Assoc Med Bras; 1972 Sep; 18(9):349-54. PubMed ID: 4539257
    [No Abstract]   [Full Text] [Related]  

  • 11. Rifampicin--a leading drug in the therapy of tuberculosis not easily amenable to treatment.
    Tousek J
    Respiration; 1971; 28():Suppl:116-22. PubMed ID: 5150791
    [No Abstract]   [Full Text] [Related]  

  • 12. [Humoral and bacteriological findings in patients with pulmonary tuberculosis during rifampicin therapy].
    Stringa C
    G Ital Mal Torace; 1969; ():Suppl 2:107-8. PubMed ID: 5357133
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rifampicin in the treatment of chronic pulmonary tuberculosis. Preliminary report].
    Pacheco CR; Cordero O; López-Malagón S; Sierra D; De Jesús Pacheco M; Vázquez E
    Gac Med Mex; 1973 Jun; 105(6):541-7. PubMed ID: 4731993
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of Soviet-made rifampicin in pulmonary tuberculosis].
    Mamolat AS; Bialik IB; Kolesnikova ZhIa; Petrash OV
    Vrach Delo; 1978 Oct; (10):52-6. PubMed ID: 716359
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preliminary clinical experiences with rifampicin in monotherapy of recent pulmonary tuberculosis].
    Briccarello L; Ferraro U
    G Ital Mal Torace; 1969; ():Suppl 2:75-7. PubMed ID: 5357146
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 1. A preliminary study. The results of Rifampicin treatment for advanced pulmonary tuberculosis resistant to conventional antituberculous drugs].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):251-6. PubMed ID: 5460317
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rifampicin and ethambutol in treating chronic destructive pulmonary tuberculosis].
    Roslik SM; Iakovleva LM; Zhitnaia VI; Grushevskiĭ ES; Poluianova RP
    Probl Tuberk; 1980 Jun; (6):30-3. PubMed ID: 7393907
    [No Abstract]   [Full Text] [Related]  

  • 18. [Monotherapy and combined therapy using rifampicin in 156 tuberculous patients].
    Laumen F
    Prax Pneumol; 1970 Mar; 24(3):158-68. PubMed ID: 5437055
    [No Abstract]   [Full Text] [Related]  

  • 19. Trial of rifampicin in the treatment of pulmonary tuberculosis. A preliminary report.
    Sriyabhaya N; Jarumilin A
    J Med Assoc Thai; 1971 May; 54(5):304-11. PubMed ID: 5580059
    [No Abstract]   [Full Text] [Related]  

  • 20. Double blind clinical trial with rimactane in salvage cases of pulmonary tuberculosis.
    Viswanathan R; Rao PU; Singh MM; Dusaj M; Sarkar DK; Bhakta US
    Indian J Med Res; 1972 Feb; 60(2):312-6. PubMed ID: 4556246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.